Related Experiment Video
Updated: Feb 6, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
Precision medicine in cholangiocarcinoma
Antonio Pellino1, Fotios Loupakis2, Massimiliano Cadamuro3
1Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy.
Cholangiocarcinoma, a challenging cancer, shows significant tumor heterogeneity. Recent research highlights its genomic landscape and molecular players, paving the way for precision medicine and improved treatments.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Cholangiocarcinoma (CCA) is an aggressive epithelial cancer with poor prognosis and limited therapeutic options.
- CCA has been historically understudied, leading to unresolved clinical management challenges.
- Tumor heterogeneity in CCA necessitates a precision medicine approach for effective treatment.
Purpose of the Study:
- To review the current understanding of the genomic landscape of cholangiocarcinoma.
- To identify emerging prognostic and predictive biomarkers for CCA.
- To discuss novel therapeutic strategies, including targeted and immunotherapies, for CCA precision medicine.
Main Methods:
- Comprehensive review of recent studies on cholangiocarcinoma genomics and molecular profiling.
- Analysis of identified molecular players, including tyrosine kinase receptors, metabolic enzymes, and chromatin-remodelling proteins.
- Evaluation of the role of the tumor microenvironment in CCA progression.
Main Results:
- Identification of numerous molecular players and aberrant expressions contributing to CCA invasiveness.
- Emergence of prognostic and predictive biomarkers from genomic landscape studies.
- Evidence of stromal microenvironment's significant role in promoting CCA via paracrine signals.
Conclusions:
- Understanding the genomic complexity and heterogeneity of cholangiocarcinoma is crucial.
- Emerging biomarkers offer potential for improved patient stratification and treatment selection.
- Innovative therapies, including targeted and immunotherapies, are advancing precision medicine for cholangiocarcinoma.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Accuracy and Precision
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Precise Definition of a Limit
The Placebo Effect

